Content Provider for Newsweek

13 May 2024

The New Era of Life Sciences 2024

This report captures a historical moment for life sciences. What were dreams or vague projections until recently are now solidifying realities. Highly personalized oncology therapies, the possibility of early cancer detection via a simple blood draw, AI’s optimization of drug discovery, unseen breakthroughs in the formerly stagnating fields of neurology or dermatology - inspiring illustrations of each of these, and more, can be found in this piece, the result of more than 100 conversations with industry leaders.

 

WRITERS: Konstantin Tumanov & Ignacio Louzan

PROJECT DIRECTORS: George Clarke & Lewis Hart

Fun Facts

Previous
Next
Life sciences FDA approved

71 new medicines have been approved by the FDA in 2023 

Source: Nature

Life Sciences IPOs

Biotech IPOs reached pre-pandemic levels during Q1 of 2024. 

Source: BioPharma Dive

Life sciences AI investments

The total investment in AI-mediated drug discovery is expected to reach $8 billion by 2030.

Source: Fortune Business Insight